The official blog of the Lung Institute.
Since 2007, national Lung Transplant Survival Rates have remained stable, while short-term survival rates of 30 days and one year have steadily improved. For patients with advanced lung disease, a lung transplant can improve their prognosis. Those who undergo a successful lung transplant operation often survive three years or more after surgery. According to the National Heart, Lung, and Blood Institute at the National Institutes of Health, more than half of single-lung-transplant patients survive at least five years after surgery.
Lung transplant prognosis depends on factors which include:
- age, gender, and diagnosis
- length of time the organ was stored before transplantation
- type of lung transplant (left, right, or double lung)
- patient response to anti-rejection medications
- whether the patient has experienced a previous lung transplant
The Scientific Registry of Transplant Recipients (SRTR) released the following statistics
in its July 2015 report:
- the national one-month adult expected survival rate is 96.85 percent.
- the national one-year adult expected survival rate is 87.47 percent.
- the national three-year adult expected survival rate is 68.23 percent.
Many people who suffer from lung disease have slowed the progression of their ailment following stem cell therapy at the Lung Institute. If you or a loved one suffers from COPD, contact one of our patient coordinators today by calling (800) 729-3065 to see if you are a candidate for stem cell therapy.